Category Archives: Policy News

Utah’s vibrant life sciences industry was on full display yesterday as part of the Governor’s Office of Economic Development’s “Industry Day on the Hill”. The event, held at the state capitol, provided legislators the opportunity to interact one-on-one with company exhibitors from the aerospace, life sciences and tech industries. Representing the life sciences sector were […]

In his State of the Union address February 5, President Trump highlighted a number of health policy goals, including lowering prescription drug prices. Drug pricing continues to be a priority for the Administration and a hot topic of debate for Republicans and Democrats alike. Trump specifically pledged to tackle high drug prices, increase transparency, work […]

Game On: Groups Launch Competing Drug Pricing Ad Campaigns  With prospects dim, at least in the short-term, for passage of comprehensive drug pricing legislation in Congress, some Washington observers suggest President Trump is eager to push for regulatory changes in an effort to capture the high ground on lowering prescription drug costs ahead of the […]

The Senate on Thursday passed President Trump’s United States-Mexico-Canada Agreement (USMCA) by a wide bipartisan vote of 89-10. The USMCA, which rewrites the North America Free Trade Agreement, will now be sent to the President’s desk to be signed into law. The President is expected to sign the measure next week. Both Utah Senators, Mike […]

Sen. Grassley Calls on Pelosi to Support His Bill Conservative Group Backs GOP Drug Pricing Alternative As we head into 2020 election season, Democrats and Republicans alike will be working to convince voters that they have the right “prescription” to lower drug costs. At present, several different approaches are circling. With the passage of H.R. […]

The Medical Device Manufacturers Association (MDMA), along with AdvaMed and the Medical Imaging Technology Association, is circulating a letter for sign on by stakeholders who support repeal of the medical device tax. As you know, unless Congress acts, the tax will take effect January 1, 2020. MDMA spearheaded a similar broad-based coalition letter in 2009, […]

Drug pricing legislation moving through Congress could force medical device manufacturers to report the value of product samples given to certain healthcare providers. This could include free samples a doctor uses when educating patients on device use. AdvaMed and the Medical Device Manufacturers Association, along with state-based affiliates, including BioUtah, are urging policymakers to exclude […]

We’re excited to announce that as of May 1, BioUtah has opened new offices downtown at 230 East South Temple, Suite 100, in the Price Real Estate building. The new office space will allow us to raise the visibility of BioUtah, better serve our members, and continue to advance Utah’s life sciences industry. BioUtah members […]